Physician profile

Russell M Lee

Pulmonary Disease · Colorado Springs, CO

NPI 1629131727

$10,758.48

in general payments reported to CMS, 2019-2025

54 companies · $1,662 in 2025

The $1,662 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$4,549.44
Education$117.33

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Astrazeneca Pharmaceuticals Lp $1,938.01 2019-2025 Breztri, Fasenra, Imfinzi
Boehringer Ingelheim Pharmaceuticals, INC. $848.65 2019-2025 Ofev
United Therapeutics Corporation $724.63 2019-2025 Tyvaso, Orenitram, Remodulin
Glaxosmithkline, LLC. $645.18 2019-2025 Trelegy Ellipta, Nucala
Actelion Pharmaceuticals US, INC. $643.19 2019-2023 Uptravi, Opsumit
Genzyme Corporation $641.61 2019-2025
Regeneron Healthcare Solutions, INC. $462.82 2021-2025 Dupixent
Grifols USA, LLC $423.26 2019-2025 Prolastin-C Liquid
Bayer Healthcare Pharmaceuticals INC. $413.36 2019-2025
E.R. Squibb & Sons, L.L.C. $263.09 2019-2023 Eliquis
Pulmonx Corporation $238.57 2019-2021
Insmed, INC. $230.41 2019-2025 Arikayce, Brinsupri
Genentech USA, INC. $225.88 2019-2025 Tecentriq
Takeda Pharmaceuticals U.S.A., INC. $220.95 2020-2025 Glassia
Inari Medical, INC. $218.53 2023-2024 Ct Thrombectomy System Kit, Flowtriever Catheter, S
Show all 54 companies
CompanyGeneral paymentsYearsTop products
Merck Sharp & Dohme LLC $210.14 2019-2025 Winrevair
Amgen INC. $182.24 2021-2025 Tezspire, Tavneos
Sanofi-Aventis U.S. LLC $157.94 2022-2025
Novartis Pharmaceuticals Corporation $154.21 2019-2023
Baxter Healthcare $152.38 2022-2025 Hillrom - Life 2000 Ventilation System, Hillrom - Vest System Model 105 Home Care
Abbvie INC. $150.41 2022-2024
Sunovion Pharmaceuticals INC. $140.66 2019-2020
Intuitive Surgical, INC. $134.26 2025
Mylan Specialty L.P. $111.07 2019-2024 Yupelri
Alexion Pharmaceuticals, INC. $99.74 2020-2023 Ultomiris
Pfizer INC. $95.04 2019-2023
Philips North America LLC $87.95 2020-2025 Vest Therapy Und
Axsome Therapeutics, INC. $78.89 2023-2025 Sunosi
Harmony Biosciences LLC $70.09 2022-2023 Wakix
Astellas Pharma US INC $69.77 2022-2024 Cresemba
Allergan, INC. $69.58 2019-2020
Gilead Sciences, INC. $61.63 2019-2022
Jazz Pharmaceuticals INC. $59.48 2022-2025
Mallinckrodt Hospital Products INC. $52.04 2022-2025 Acthar
Avadel Cns Pharmaceuticals, LLC $49.56 2023-2025 Lumryz
Verona Pharma, INC. $45.91 2025 Ohtuvayre
Teva Pharmaceuticals USA, INC. $39.57 2019-2022
Vapotherm INC $33.72 2019
Csl Behring $31.46 2019-2020
Electromed, INC. $27.77 2025 Smartvest
Ucb, INC. $23.51 2019
Vifor Pharma, INC. $23.23 2024 Zemaira
Olympus America INC. $23.07 2020
Inogen, INC. $22.11 2022
Bard Peripheral Vascular, INC. $20.06 2025 Pleurx
Biogen, INC. $19.80 2019
Pharming Healthcare, INC. $19.65 2023 Ruconest
Circassia INC. $18.22 2019
Shire North American Group INC $17.73 2019
La Jolla Pharmaceutical Company $17.22 2024 Giapreza
Movair INC $15.55 2025 Luisa
Aytu Biopharma, INC. $13.92 2019
Portola Pharmaceuticals, LLC $10.95 2019
Janssen Pharmaceuticals, INC $9.81 2020

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Russell M Lee

$10,758.48

in general payments reported 2019-2025

Years
2019-2025
Top company
Astrazeneca Pharmaceuticals Lp
Context
The $1,662 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).

https://glasscript.com/doctor/28708/russell-m-lee

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.